Haleon Hopes Pathbreaking Eroxon Will ‘Resonate’ With US ED Sufferers

October will see the bricks-and-mortar launch of the first FDA-approved OTC treatment for erectile dysfunction in the US by Haleon. HBW Insight catches up with the company's North America president Lisa Paley to find out what Haleon has planned for Eroxon's arrival in stores. 

• Source: Haleon

Next month Haleon plc will become the first consumer health company to launch an FDA-approved OTC treatment for erectile dysfunction.

In what it described as a “bold step,” Haleon backed UK R&D firm Futura Medical plc’s drug-free ED gel...

More from United States

More from Leadership